Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bradley Stovall

Physical Medicine & Rehabilitation Henrico, VA Doctor of Osteopathy

NPI 1053607945 CMS profile 592447

11958 W Broad St, Henrico, VA 23233

Open in the dashboard

General payments

$4,863

72 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bradley Stovall of Henrico, VA is reported in the CMS Open Payments database as having received $4,863 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $512 9
2024 General $50 2
2023 General $305 8
2022 General $745 15
2021 General $948 14
2020 General $301 5
2019 General $2,002 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradley Stovall
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Bradley Stovall were reported at $512. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Bradley Stovall Physical Medicine & Rehabilitation median Middle half National median
2019 $2,002 $133 $45–$390 $163
2020 $301 $88 $29–$272 $114
2021 $948 $116 $33–$360 $132
2022 $745 $123 $40–$378 $149
2023 $305 $131 $43–$396 $160
2024 $50 $141 $45–$409 $164
2025 $512 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $2,191 20 payments
  2. Medtronic, Inc. $1,477 30 payments
  3. Relievant Medsystems, Inc. $658 12 payments
  4. Boston Scientific Corporation $269 4 payments
  5. Abbott Laboratories $187 2 payments
  6. Stryker Corporation $40 1 payment
  7. Avanos Medical $18 1 payment
  8. Nevro Corp. $14 1 payment
  9. MML US, Inc. $8 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,366 67 payments
  2. Travel and Lodging $1,497 5 payments
Products named General payments · program years 2019–2025
  1. KYPHON Balloon Kyphoplasty $1,325 6 payments
  2. INTELLIS ADAPTIVESTIM $905 21 payments
  3. Intracept Pain $610 9 payments
  4. Intracept Pain $610 9 payments
  5. INTELLIS Spinal Cord Neurostimulation $536 8 payments
  6. RESTORE $330 6 payments
  7. INCEPTIV $235 4 payments
  8. Intracept Intracept Access Instruments (Gen 3)_NMOD $220 3 payments
  9. INTELLIS Spinal Cord Neurostimulation $154 1 payment
  10. ITREL $152 1 payment
  11. Other $444 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

1,222

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$11,340

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

6.5%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 192 $3,995
Gabapentin Generic 371 $3,418
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 79 $776
Methylprednisolone Generic 95 $644
Tramadol Hcl Generic 117 $502
Baclofen Generic 52 $495
Tizanidine Hcl Generic 38 $394
Methocarbamol Generic 79 $365
Duloxetine Hcl Generic 15 $257
Cyclobenzaprine Hcl Generic 43 $173

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$328,321

Of which drugs: $637

Medicare patients

686

Average age 75

Services billed

8,933

433 women, 253 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 29%
Diabetes 26%
Depression 23%
Osteoporosis 22%
Chronic kidney disease 20%
Cancer 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 304 3,670 $327
Injection, methylprednisolone acetate, 1 mg J1010 Office 49 2,280 $228
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 341 528 $56

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record